Stay updated on Sitravatinib for Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Sitravatinib for Metastatic Breast Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the expected study record for NCT04123704, indicating an access restriction. This blocks viewing the study details on ClinicalTrials.gov.SummaryDifference18%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6. This reflects a new version of the study record and associated documents, without altering the trial details.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.6.5 is now shown on the page, replacing v3.6.4. This reflects a new version of the page; no study content or user-facing features are changed.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision label on the page updated from v3.6.3 to v3.6.4. This represents a minor backend/software update rather than a change to the study content or user-facing information.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page now shows revision v3.6.3, replacing the previous v3.6.2. This indicates a minor site update rather than changes to the study details.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2 to reflect an internal update to the page template or backend.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib for Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.